Performance of various continuous variables in predicting disease progression in distant metastasis differentiated thyroid cancer patients
| . | Se . | Sp . | Youden index . | Cutoff . |
|---|---|---|---|---|
| NLR | 0.712 | 0.473 | 0.185 | 1.59 |
| PLR | 0.610 | 0.482 | 0.092 | 123.20 |
| LMR | 0.322 | 0.910 | 0.233 | 4.63 |
| SII | 0.847 | 0.357 | 0.205 | 316.22 |
| sTg | 0.831 | 0.607 | 0.438 | 61.85(μg/mL) |
| . | Se . | Sp . | Youden index . | Cutoff . |
|---|---|---|---|---|
| NLR | 0.712 | 0.473 | 0.185 | 1.59 |
| PLR | 0.610 | 0.482 | 0.092 | 123.20 |
| LMR | 0.322 | 0.910 | 0.233 | 4.63 |
| SII | 0.847 | 0.357 | 0.205 | 316.22 |
| sTg | 0.831 | 0.607 | 0.438 | 61.85(μg/mL) |
Abbreviations: LMR, lymphocyte-to-monocyte ratio; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; Se, sensitivity; SII, systemic immune-inflammation index; Sp, specificity; sTg, stimulated thyroglobulin.
Performance of various continuous variables in predicting disease progression in distant metastasis differentiated thyroid cancer patients
| . | Se . | Sp . | Youden index . | Cutoff . |
|---|---|---|---|---|
| NLR | 0.712 | 0.473 | 0.185 | 1.59 |
| PLR | 0.610 | 0.482 | 0.092 | 123.20 |
| LMR | 0.322 | 0.910 | 0.233 | 4.63 |
| SII | 0.847 | 0.357 | 0.205 | 316.22 |
| sTg | 0.831 | 0.607 | 0.438 | 61.85(μg/mL) |
| . | Se . | Sp . | Youden index . | Cutoff . |
|---|---|---|---|---|
| NLR | 0.712 | 0.473 | 0.185 | 1.59 |
| PLR | 0.610 | 0.482 | 0.092 | 123.20 |
| LMR | 0.322 | 0.910 | 0.233 | 4.63 |
| SII | 0.847 | 0.357 | 0.205 | 316.22 |
| sTg | 0.831 | 0.607 | 0.438 | 61.85(μg/mL) |
Abbreviations: LMR, lymphocyte-to-monocyte ratio; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; Se, sensitivity; SII, systemic immune-inflammation index; Sp, specificity; sTg, stimulated thyroglobulin.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
